We make AI-powered diagnostic software for hospitals. Our model for COVID-19 screening is the largest application of artificial intelligence to COVID yet, with data spanning over 60 US-based hospitals and 200,000 patients.
Our work is funded by some of the most prestigious organizations in science and technology, including the National Institutes of Health, the National Science Foundation, and startup incubator Y Combinator.
A former faculty member at the National Institutes of Health with over 20 peer-reviewed publications, Artur has built the flight controller software for the world's largest electric "flying car", helped Twitter scale its revenues from under $100M to over $2B, and presently leads the vision and AI at Biocogniv.
Prior to Biocogniv, Tanya was the COO/CTO at the cancer diagnostics company Genomic Expression. She has a PhD in Physical Chemistry from McGill and co-founded a life science instrumentation company (BioTrove, acq. '09) to commercialize the post-doctoral research she did at MIT.
Dr. Joe is a Harvard-affiliated Massachusetts General Hospital (MGH) and Brigham and
Women’s Hospital (BWH) nephrology graduate and emergency room doctor. She is the cofounder of Medstro & MedTech Boston (acq. '18), and a national thought leader in digital health.
Mohsen has a PhD from Caltech in Molecular Biophysics and Computer Science, where he focused on parallel and stochastic algorithms applied to the protein folding problem. Among his past experiences, he has worked at Goldman Sachs, Symantec, JP Morgan and Alpha Beta Investments.
With 20+ years of software engineering experience, John has built mission critical software for IBM, Oracle, and Twitter, led Saleforce's API team, and launched Lyft's Express Drive program from the ground up. John's most recent venture was as CTO and Co-Founder of Flex Gym Share.
Jed Batchelder is a Healthcare IT project manager with 15+ years of experience servicing health systems. In addition to leading large-scale, cloud-based healthcare implementations, Jed has provided industry expertise to healthcare IT startups, and served as strategic advisor to hospital executives around the country.
Adrian is a medical student at the University of Vermont Larner College of Medicine with an undergraduate degree in Biochemistry from Bucknell University. He is also a former lab manager at the Harvard Stem Cell Institute. Adrian is passionate about the applications of machine learning in diagnostic medicine.
Dr. Levine has been a clinical professor at Yale School of Medicine for over 40 years, and has authored and licensed over 100 patents in medical diagnostics, including several hematology devices like the Quantitative Buffer Coat, which has been commercialized to over $1B in sales.
As former COO of T2 Biosystems (IPO) and Boston Microfluidics, Sarah has spearheaded the clearance of several diagnostic devices with the FDA, and provides valuable guidance to Biocogniv's regulatory strategy.
Ed runs Larchmont Strategic Advisors and is an expert analyst of the legislative, regulatory, and economic forces that affect health care industry stakeholders. He has built a long track record of
successful management of reimbursement and other health care public policy advocacy programs.
John is a serial healthcare entrepreneur, having sold an FDA-compliant clinical trial software company to Phase Forward and then Oracle, and led product commercialization teams at various medical companies (JnJ, Abbott, Roche, Oracle, and IBM).
Dr. Weinberg is an Assistant Professor of Medicine at Cedars-Sinai, triple boarded in pulmonary, critical care, and internal medicine. He has a Master's degree from Cambridge University, and has co-authored several studies and clinical trials in critical care and pulmonary vascular medicine.
Dr. Tapson is a Professor of Medicine and Associate Director in the Pulmonary and Critical Care Division at Cedars-Sinai Medical Center. He has authored over 250 papers and has edited numerous books and chapters in pulmonology and critical care.
Dr. Plante is a physician scientist at the Larner College of Medicine at the University of Vermont, where he practices hospital and thrombosis medicine. He holds a masters degree in clinical epidemiology from John Hopkins, and researches cardiovascular disease, epidemiology, and mobile health technologies.
Dr. Siket is Associate Professor of Surgery and Neurological Sciences at the Larner College of Medicine at the University of Vermont, having taught medicine at Harvard and Brown. He practices emergency medicine and researches neurovascular diseases at UVM.